At a glance
ClinicalIndex Comparison RecordN/ACompleted· 35,921 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study)
In Brief
An observational study for General Safety Profile of DOTAREM. Completed, enrolled 35,921 participants across 10 sites in 10 countries.
Detailed Summary
The main purpose of this study is to prospectively assess the general safety profile of Dotarem
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGeneral Safety Profile of DOTAREM
CountriesArgentina, Austria, China, France, Germany, India, Italy, Saudi Arabia, Spain, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartNov 2008
First PostedFeb 2012
Primary CompletionJul 2013
TodayJul 2026
First PostedFeb 1, 2012
Enrollment StartNov 1, 2008
Primary CompletionJul 1, 2013
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 14.4 years ago